David E. Nichols

Cellular and Molecular Neuroscience · 2007–2016

A researcher in the Science corpus: 3 papers; trusts 18 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom David E. Nichols trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Nikos K. Logothetis
  2. Roland R. Griffiths
  3. Matthew W. Johnson
  4. Katherine A. MacLean
  5. M. Zentner
  6. Giulio Tononi
  7. W. A. Richards
  8. U. McCann
  9. Robin L. Carhart-Harris
  10. F. Crick

Who trusts David E. Nichols overall

  1. Robin L. Carhart-Harris
  2. Chris Letheby
  3. Leor Roseman
  4. R. Watts
  5. David J. Nutt
  6. Roland R. Griffiths

Papers from David E. Nichols's perspective

Ordered by how strongly the researchers David E. Nichols trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. (Archives of General Psychiatry)
  2. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
  3. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (Journal of Psychopharmacology)
  4. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (Nature Reviews Neuroscience)
  5. Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)
  6. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (Psychopharmacology)
  7. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (Psychopharmacology)
  8. Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (Journal of Nervous and Mental Disease)
  9. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. (Journal of Clinical Psychiatry)
  10. Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness (Journal of Psychopharmacology)

Their papers